Literature DB >> 28245136

Reduced Frizzled Receptor 4 Expression Prevents WNT/β-Catenin-driven Alveolar Lung Repair in Chronic Obstructive Pulmonary Disease.

Wioletta Skronska-Wasek1, Kathrin Mutze1, Hoeke A Baarsma1, Ken R Bracke2, Hani N Alsafadi1, Mareike Lehmann1, Rita Costa1, Mariano Stornaiuolo3, Ettore Novellino3, Guy G Brusselle2, Darcy E Wagner1, Ali Ö Yildirim1, Melanie Königshoff1,4.   

Abstract

RATIONALE: Chronic obstructive pulmonary disease (COPD), in particular emphysema, is characterized by loss of parenchymal alveolar tissue and impaired tissue repair. Wingless and INT-1 (WNT)/β-catenin signaling is reduced in COPD; however, the mechanisms thereof, specifically the role of the frizzled (FZD) family of WNT receptors, remain unexplored.
OBJECTIVES: To identify and functionally characterize specific FZD receptors that control downstream WNT signaling in impaired lung repair in COPD.
METHODS: FZD expression was analyzed in lung homogenates and alveolar epithelial type II (ATII) cells of never-smokers, smokers, patients with COPD, and two experimental COPD models by quantitative reverse transcriptase-polymerase chain reaction, immunoblotting, and immunofluorescence. The functional effects of cigarette smoke on FZD4, WNT/β-catenin signaling, and elastogenic components were investigated in primary ATII cells in vitro and in three-dimensional lung tissue cultures ex vivo. Gain- and loss-of-function approaches were applied to determine the effects of FZD4 signaling on alveolar epithelial cell wound healing and repair, as well as on expression of elastogenic components.
MEASUREMENTS AND MAIN RESULTS: FZD4 expression was reduced in human and experimental COPD lung tissues as well as in primary human ATII cells from patients with COPD. Cigarette smoke exposure down-regulated FZD4 expression in vitro and in vivo, along with reduced WNT/β-catenin activity. Inhibition of FZD4 decreased WNT/β-catenin-driven epithelial cell proliferation and wound closure, and it interfered with ATII-to-ATI cell transdifferentiation and organoid formation, which were augmented by FZD4 overexpression. Moreover, FZD4 restoration by overexpression or pharmacological induction led to induction of WNT/β-catenin signaling and expression of elastogenic components in three-dimensional lung tissue cultures ex vivo.
CONCLUSIONS: Reduced FZD4 expression in COPD contributes to impaired alveolar repair capacity.

Entities:  

Keywords:  Frizzled 4 receptor; cigarette smoke; emphysema; regeneration; smoking

Mesh:

Substances:

Year:  2017        PMID: 28245136     DOI: 10.1164/rccm.201605-0904OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  34 in total

1.  Update in Chronic Obstructive Pulmonary Disease 2017.

Authors:  William Z Zhang; Kazunori Gomi; Seyed Babak Mahjour; Fernando J Martinez; Renat Shaykhiev
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

2.  At the Root: Defining and Halting Progression of Early Chronic Obstructive Pulmonary Disease.

Authors:  Fernando J Martinez; MeiLan K Han; James P Allinson; R Graham Barr; Richard C Boucher; Peter M A Calverley; Bartolome R Celli; Stephanie A Christenson; Ronald G Crystal; Malin Fagerås; Christine M Freeman; Lars Groenke; Eric A Hoffman; Mehmet Kesimer; Kostantinos Kostikas; Robert Paine; Shahin Rafii; Stephen I Rennard; Leopoldo N Segal; Renat Shaykhiev; Christopher Stevenson; Ruth Tal-Singer; Jørgen Vestbo; Prescott G Woodruff; Jeffrey L Curtis; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

Review 3.  Tissue-informed engineering strategies for modeling human pulmonary diseases.

Authors:  Kolene E Bailey; Michael L Floren; Tyler J D'Ovidio; Steven R Lammers; Kurt R Stenmark; Chelsea M Magin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-21       Impact factor: 5.464

4.  The Wnt Signaling Pathway Is Differentially Expressed during the Bovine Herpesvirus 1 Latency-Reactivation Cycle: Evidence That Two Protein Kinases Associated with Neuronal Survival, Akt3 and BMPR2, Are Expressed at Higher Levels during Latency.

Authors:  Aspen Workman; Liqian Zhu; Brittney N Keel; Timothy P L Smith; Clinton Jones
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 5.  Applications and Approaches for Three-Dimensional Precision-Cut Lung Slices. Disease Modeling and Drug Discovery.

Authors:  Hani N Alsafadi; Franziska E Uhl; Ricardo H Pineda; Kolene E Bailey; Mauricio Rojas; Darcy E Wagner; Melanie Königshoff
Journal:  Am J Respir Cell Mol Biol       Date:  2020-06       Impact factor: 6.914

Review 6.  Distinct Roles of Wnt/β-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.

Authors:  Juan Shi; Feng Li; Meihui Luo; Jun Wei; Xiaoming Liu
Journal:  Mediators Inflamm       Date:  2017-05-09       Impact factor: 4.711

Review 7.  Perspectives on Wnt Signal Pathway in the Pathogenesis and Therapeutics of Chronic Obstructive Pulmonary Disease.

Authors:  Jiao Qu; Li Yue; Jian Gao; Hongwei Yao
Journal:  J Pharmacol Exp Ther       Date:  2019-04-05       Impact factor: 4.030

8.  The relationship between DJ-1 and S100A8 in human primary alveolar type II cells in emphysema.

Authors:  Chih-Ru Lin; Karim Bahmed; Dhanendra Tomar; Nathaniel Marchetti; Gerard J Criner; Sudhir Bolla; Mark A Wilson; Muniswamy Madesh; Beata Kosmider
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-07-17       Impact factor: 5.464

9.  Ginsenoside Rg1 protects against cigarette smoke-induced airway remodeling by suppressing the TGF-β1/Smad3 signaling pathway.

Authors:  Sibin Guan; Ping Yu; Jianhong Cao; Xiaoling Xi; Qingliu Zhang; Chenying Zhu; Hao Hu; Xin Gong; Huimin Fan
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

Review 10.  Why new biology must be uncovered to advance therapeutic strategies for chronic obstructive pulmonary disease.

Authors:  Jennifer M K Nguyen; Douglas N Robinson; Venkataramana K Sidhaye
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-11-11       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.